JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms

Journal of Cell Science

Volumn 115, Issue 22, 2002, Pages 4317-4325

  David, Jean Pierre ^a   Sabapathy, Kanaga ^a,c   Hoffman, Oskar ^b   Idarraga, Maria H ^a   Wagner, Erwin F ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Apoptosis; c Jun; Jun N terminal kinase; Osteoclasts; RANKL

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; CELL RECEPTOR; GLYCOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 9; OSTEOPROTEGERIN; STRESS ACTIVATED PROTEIN KINASE 1; TNFRSF11B PROTEIN, MOUSE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MUTANT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FEMALE; MALE; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION INITIATION; ANIMAL; ARTICLE; BINDING SITE; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; MUTATION; MYELOID PROGENITOR CELL; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALIA;

ANIMALS; APOPTOSIS; BINDING SITES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; MUTATION; MYELOID PROGENITOR CELLS; OSTEOCLASTS; OSTEOPROTEGERIN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSCRIPTION FACTOR AP-1;

EID: 0037113034     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00082     Document Type: Review

References (39)

1. Abu-Amer, Y., Ross, F. P., Edwards, J. and Teitelbaum, S. L. (1997). Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J. Clin. Invest. 100, 1557-1565.
2. Abu-Amer, Y., Erdmann, J., Alexopoulou, L., Kollias, G., Ross, F. P. and Teitelbaum, S. L. (2000). Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J. Biol. Chem. 275, 27307-27310.
3. Arbour, N., Naniche, D., Homann, D., Davis, R. J., Flavell, R. A. and Oldstone, M. B. (2002). c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity. J. Exp. Med. 195, 801-810.
4. Behrens, A., Sibilia, M. and Wagner, E. F. (1999). Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21, 326-329.
5. Behrens, A., Jochum, W., Sibilia, M. and Wagner, E. F. (2000). Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19, 2657-2663.
6. Behrens, A., Sabapathy, K., Graef, I., Cleary, M., Crabtree, G. R. and Wagner, E. F. (2001). Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). Proc. Natl. Acad. Sci. USA 98, 1769-1774.
7. Behrens, A., Sibilia, M., David, J. P., Mohle-Steinlein, U., Tronche, F., Schutz, G. and Wagner, E. F. (2002). Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J. 21, 1782-1790.
8. Brown, K. D., Hostager, B. S. and Bishop, G. A. (2001). Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J. Exp. Med. 193, 943-954.
9. Chan, F. K. and Lenardo, M. J. (2000). A crucial role for p8O TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur. J. Immunol. 30, 652-660.
10. Chang, L. and Karin, M. (2001). Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
11. Constant, S. L., Dong, C., Yang, D. D., Wysk, M., Davis, R. J. and Flavell, R. A. (2000). JNK1 is required for T cell-mediated immunity against Leishmania major infection. J. Immunol. 165, 2671-2676.
12. David, J. P., Rincon, M., Neff, L., Horne, W. C. and Baron, R. (2001). Carbonic anhydrase II is an AP-1 target gene in osteoclasts. J. Cell Physiol. 188, 89-97.
13. Davis, R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
14. Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J. and Flavell, R. A. (1998). Defective T cell differentiation in the absence of Jnk1. Science 282, 2092-2095.
15. Duckett, C. S. and Thompson, C. B. (1997). CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11, 2810-2821.
16. Han, Z., Boyle, D. L., Chang, L., Bennett, B., Karin, M., Yang, L., Manning, A. M. and Firestein, G. S. (2001). c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108, 73-81.
17. Han, Z., Chang, L., Yamanishi, Y., Karin, M. and Firestein, G. S. (2002). Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. Arthritis Rheum. 46, 818-823.
18. Hochedlinger, K., Wagner, E. F. and Sabapathy, K. (2002). Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis. Oncogene 21, 2441-2445.
19. Inoue, J., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S. and Yamamoto, T. (2000). Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254, 14-24.
20. Jochum, W., Passegue, E. and Wagner, E. F. (2001). AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412.
21. Karsenty, G. and Wagner, E. F. (2002). Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406.
22. Kuan, C. Y., Yang, D. D., Samanta Roy, D. R., Davis, R. J., Rakic, P. and Flavell, R. A. (1999). The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667-676.
23. Lee, S. Y., Reichlin, A., Santana, A., Sokol, K. A., Nussenzweig, M. C. and Choi, Y. (1997). TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 7, 703-713.
24. Li, X., Yang, Y. and Ashwell, J. D. (2002). TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416, 345-347.
25. Manolagas, S. C. (2000). Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21, 115-137.
26. Sabapathy, K., Hu, Y., Kallunki, T., Schreiber, M., David, J. P., Jochum, W., Wagner, E. F. and Karin, M. (1999a). JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9, 116-125.
27. Sabapathy, K., Jochum, W., Hochedlinger, K., Chang, L., Karin, M. and Wagner, E. F. (1999b). Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. 89, 115-124.
28. Sabapathy, K., Kallunki, T., David, J. P., Graef, I., Karin, M. and Wagner, E. F. (2001). c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J. Exp. Med. 193, 317-328.
29. Schaeffer, H. J., Catling, A. D., Eblen, S. T., Collier, L. S., Krauss, A. and Weber, M. J. (1998). MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281, 1668-1671.
30. Shevde, N. K., Bendixen, A. C., Dienger, K. M. and Pike, J. W. (2000). Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc. Natl. Acad. Sci. USA 97, 7829-7834.
31. Srivastava, S., Weitzmann, M. N., Cenci, S., Ross, F. P., Adler, S. and Pacifici, R. (1999). Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 104, 503-513.
32. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T. and Martin, T. J. (1999). Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357.
33. Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K. et al. (2000). T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408, 600-605.
34. Thepot, D., Weitzman, J. B., Barra, J., Segretain, D., Stinnakre, M. G., Babinet, C. and Yaniv, M. (2000). Targeted disruption of the murine junD gene results in multiple defects in male reproductive function. Development 127, 143-153.
35. Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A. and Davis, R. J. (2000). Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-874.
36. Yang, D. D., Kuan, C. Y., Whitmarsh, A. J., Rincon, M., Zheng, T. S., Davis, R. J., Rakic, P. and Flavell, R. A. (1997). Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870.
37. Yang, D. D., Conze, D., Whitmarsh, A. J., Barrett, T., Davis, R. J., Rincon, M. and Flavell, R. A. (1998). Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9, 575-585.
38. Yeh, W. C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L., Ferrick, D., Hum, B., Iscove, N. et al. (1997). Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725.
39. Zhang, Y. H., Heulsmann, A., Tondravi, M. M., Mukherjee, A. and Abu-Amer, Y. (2001). Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J. Biol. Chem. 276, 563-568.